You have 9 free searches left this month | for more free features.

low-grade oligodendroglioma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

High-grade Glioma, Oligodendroglioma, Astrocytoma Trial (Low-dose OKN-007, BID, Low-dose OKN-007, TID, Mid-dose OKN-007, TID)

Not yet recruiting
  • High-grade Glioma
  • +3 more
  • Low-dose OKN-007, BID
  • +3 more
  • (no location specified)
Sep 26, 2022

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion Trial in France (PCV chemo, Radiotherapy and PCV chemo)

    Recruiting
    • Oligodendroglioma
    • +2 more
    • PCV chemotherapy
    • Radiotherapy and PCV chemotherapy
    • Amiens, France
    • +25 more
    Jun 14, 2022

    Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas Trial in San Francisco (Everolimus,

    Terminated
    • Low Grade Glioma
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    Nov 3, 2021

    Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,

    Active, not recruiting
    • Adult Anaplastic Astrocytoma
    • +15 more
    • biopsy
    • +7 more
    • Rochester, Minnesota
      Mayo Clinic
    Apr 8, 2022

    Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

    Recruiting
    • Glioblastoma
    • +3 more
    • Adaptive Radiotherapy
    • New York, New York
      Columbia University Irving Medical Center
    Oct 27, 2023

    Adult Brain Tumor, Adult Brain Stem Glioma, Adult Diffuse Astrocytoma Trial in Philadelphia (radiation, procedure, other)

    Completed
    • Adult Brain Tumor
    • +11 more
    • proton beam radiation therapy
    • +2 more
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of The University of Pennsylvania
    Dec 8, 2020

    Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

    Active, not recruiting
    • Oligodendroglioma
    • +5 more
    • GBM6-AD and poly-ICLC before and after surgery
    • GBM6-AD and poly-ICLC after surgery only
    • San Francisco, California
      University of California
    Sep 20, 2022

    Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in Los Angeles (tumor lysate-pulsed autologous

    Completed
    • Adult Diffuse Astrocytoma
    • +4 more
    • tumor lysate-pulsed autologous dendritic cell vaccine
    • laboratory biomarker analysis
    • Los Angeles, California
      Jonsson Comprehensive Cancer Center
    Oct 14, 2020

    Glioblastoma, Astrocytoma, Oligodendroglioma Trial (OKN-007)

    Withdrawn
    • Glioblastoma
    • +2 more
    • (no location specified)
    Oct 5, 2022

    Oligodendroglioma Trial in Zhengzhou (Tislelizumab plus Bevacizumab)

    Recruiting
    • Oligodendroglioma
    • Tislelizumab plus Bevacizumab
    • Zhengzhou, Henan, China
      Henan Provincial People's Hospital
    Aug 21, 2022

    Gliomas Trial in Houston (Ulixertinib)

    Not yet recruiting
    • Gliomas
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 12, 2023

    Low-Grade Glioma, Recurrent Low-Grade Glioma, Progressive Low-Grade Glioma Trial in Memphis (Mirdametinib)

    Recruiting
    • Low-Grade Glioma
    • +2 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 24, 2022

    Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

    Recruiting
    • Anaplastic Astrocytoma, IDH-Wildtype
    • +8 more
    • Quality-of-Life Assessment
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 8, 2022

    Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by

    Recruiting
    • Recurrent High-grade Glioma
    • +3 more
    • 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
    • +2 more
    • Incheon, Korea, Republic of
      Gachon University Gil Medical Center
    Feb 19, 2023

    Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

    Completed
    • Glioma
    • +7 more
    • Neural stem cells loaded with an oncolytic adenovirus
    • Duarte, California
    • +1 more
    Dec 28, 2022

    Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

    Not yet recruiting
    • Recurrent High Grade Glioma
    • +4 more
    • (no location specified)
    Jan 24, 2023

    Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

    Withdrawn
    • Recurrent Anaplastic Astrocytoma
    • +7 more
    • Neural Stem Cells-expressing CRAd-S-pk7
    • Resection
    • (no location specified)
    Nov 22, 2022

    Low-grade Glioma Trial in Toronto (Saturation Transfer (ST)-MRI)

    Recruiting
    • Low-grade Glioma
    • Saturation Transfer (ST)-MRI
    • Toronto, Ontario, Canada
    • +1 more
    Aug 10, 2023

    Astrocytoma, Oligodendroglioma, Oligodendroastrocytoma Trial in Guangzhou (Radiotherapy, Temozolomide)

    Recruiting
    • Astrocytoma
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    May 26, 2020

    Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma Trial in San Francisco (Everolimus, Archival Tissue

    Completed
    • Adult Diffuse Astrocytoma
    • +4 more
    • San Francisco, California
      University of California, San Francisco
    Jul 24, 2020

    Low-grade Oral Dysplasia Trial in Boston (Probiotic oral lozenges, Standard of care for oral dysplasia)

    Not yet recruiting
    • Low-grade Oral Dysplasia
    • Probiotic oral lozenges
    • Standard of care for oral dysplasia
    • Boston, Massachusetts
      Boston Medical Center
    Jan 22, 2023

    Low Grade Serous Ovarian Carcinoma and Uterine Involvement :

    Completed
    • Serous Ovarian Carcinoma
    • Low Grade Serous Ovarian Carcinoma
    • Rate of myometrial involvement in the population of 28 low grade serous ovarian carcinoma.
    • Lyon, France
      Hospices civils de Lyon
    Feb 14, 2023

    HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions, HPV Infection Trial in Wenzhou (CO2)

    Recruiting
    • HPV-Related Cervical Carcinoma
    • +3 more
    • CO2
    • Wenzhou, Zhejiang, China
      first affiliated hospital of Wenzhou medical university
    Sep 23, 2023

    Astrocytoma, Oligodendroglioma, Adult, Glioma, Malignant Trial in Saint Louis (temporally-modulated pulsed radiotherapy (TMPRT))

    Recruiting
    • Astrocytoma
    • +2 more
    • temporally-modulated pulsed radiotherapy (TMPRT)
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 19, 2023